High-Purity 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine: Key to Ibrutinib Synthesis
Unlock advanced pharmaceutical synthesis with our high-purity intermediate, crucial for Ibrutinib and BTK inhibitor development.
Get a Quote & SampleProduct Core Value
![3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](https://www.nbinno.com/webimg/gemini_688eb202d8c88_1754182146.png)
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
This compound is a vital building block in the pharmaceutical industry, particularly noted for its role as a key intermediate in the synthesis of Ibrutinib, a significant BTK inhibitor. Its high purity ensures the efficacy and quality of the final drug product, making it indispensable for pharmaceutical research and production.
- High Purity for Critical Applications: With a purity of 98% minimum, this Ibrutinib intermediate CAS 330786-24-8 guarantees reliable performance in complex chemical syntheses.
- Essential for BTK Inhibitor Production: The compound plays a critical role in the BTK inhibitor synthesis intermediate process, supporting the development of targeted cancer therapies.
- Versatile Organic Synthesis Intermediate: Beyond Ibrutinib, its structure makes it valuable for various organic synthesis intermediates for cancer drugs and other complex molecular constructions.
- Quality Assurance in Chemical Manufacturing: Sourced and produced to stringent standards, this chemical ensures consistency and quality in every batch for pharmaceutical production of Ibrutinib.
Advantages You'll Experience
Reliable Synthesis Pathway
Leverage the established 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine synthesis methods to streamline your drug development process.
Enhanced Efficacy of Final Product
Utilizing this intermediate contributes to the overall effectiveness of Ibrutinib as a treatment for various cancers, embodying the precision of high purity pharmaceutical intermediates.
Streamlined R&D and Production
Its availability and well-defined properties support efficient organic synthesis intermediates for cancer drugs, from laboratory scale to commercial production.
Key Applications
Ibrutinib Synthesis
This compound is indispensable for the pharmaceutical production of Ibrutinib, a vital medication for specific hematological malignancies.
Pharmaceutical Intermediates
Serves as a critical component in the broader field of pharmaceutical intermediates, enabling the creation of complex active pharmaceutical ingredients.
Organic Synthesis
Its versatile chemical structure makes it a valuable reagent in general organic synthesis, supporting the creation of novel compounds.
Laboratory Research
Essential for academic and industrial research, particularly in exploring new therapeutic avenues and refining existing BTK inhibitor synthesis intermediate processes.